News
Gross margin of 71.2% increased over 160 basis points year-over-year, and optimism for new product lines, In Q1 2025, revenue declined by 3% year-over-year, but excluding headwinds of $16 million, ...
Researchers identified that triterpene glycosides from the starfish Solaster pacificus can kill drug-resistant prostate ...
Royal Philips recently announced FDA 510(k) clearance of the latest version of the company’s UroNav system for image-guided ...
Most of its precision oncology products, including Lorbrena, Braftovi, Mektovi, and Talzenna, posted double-digit increases ...
Cleveland Diagnostics — spun off from Cleveland Clinic Innovations — has a unique prostate test that has seen the business ...
(ST. JOSEPH, Mo) Mosaic Life Care is advancing its cancer treatment for patients with metastatic prostate cancer. PLUVICTO is ...
Ryne Sandberg never sought the spotlight, but as Rick Telander writes for Fox 32, his greatness was impossible to miss.
After my cancer diagnosis, I planned to go it alone but found unconditional acceptance from the cancer community once I took the first step.
In June this year, Paul Henderson received test results showing elevated PSA levels. In this weekly diary, he will be sharing ...
Choice of therapy to control high blood sugar may affect survival among older adults with cancer and type 2 diabetes, according to study results.Those who used GLP-1 receptor agonists exhibited ...
If Telix can crack a better therapy for key cancers in its remit, its $7 billion market valuation looks only the start, ...
Average selling prices of Illuccix will likely decrease when its transitional pass-through payment status expires in 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results